Literature DB >> 7531101

Substance P receptors and signal transduction in leukocytes.

A Kavelaars1, F Jeurissen, C J Heijnen.   

Abstract

In this paper we demonstrate several aspects of the mechanisms of action of the neurotransmitter Substance P in the immune system. We describe how Substance P can activate T cells, B cells, monocytes, and granulocytes to, respectively, proliferation, immunoglobulin synthesis, cytokine production, and chemotaxis. However, the neurotransmitter does not trigger cells of the immune system only via the well-characterized neurokinin-1 receptor, which mediates the signaling by Substance P in the neuroendocrine system. We show that Substance P can activate T cells receptor-independently. The receptor-independent activation of T cells leads to the activation of heterotrimeric G proteins and calcium-influx into the T cell, followed by an increase in proliferation of the cell. Apart from the receptor-independent activation pathway, Substance P can also activate monocytes and B cells via a nonneurokinin Substance P receptor. Activation of this novel receptor leads to the activation of MAP kinase, which is an important second messenger in the cascade leading to cytokine production by monocytes. In contrast to the non-neurokinin Substance P receptor, triggering of the NK-1 receptor, transfected in Jurkat cells, or triggering of T cells via receptor-independent pathways does not lead to activation of MAP kinase. Combining the data, we can conclude that the interaction between the neuroendocrine system and the immune system with regard to Substance P clearly indicates that the immune system does not necessarily mirror the communication pathways that are used in the neuroendocrine system. Substance P is capable of signaling the immune system via multiple activation pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531101     DOI: 10.1006/immu.1994.1036

Source DB:  PubMed          Journal:  Immunomethods        ISSN: 1058-6687


  4 in total

1.  Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum.

Authors:  Ioana M Sonea; Mitchell V Palmer; Dhuha Akili; James A Harp
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 2.  Substance P in heart failure: the good and the bad.

Authors:  Heather M Dehlin; Scott P Levick
Journal:  Int J Cardiol       Date:  2013-11-12       Impact factor: 4.164

3.  Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists.

Authors:  A Molinos-Quintana; P Trujillo-Hacha; J I Piruat; J A Bejarano-García; E García-Guerrero; J A Pérez-Simón; Miguel Muñoz
Journal:  Invest New Drugs       Date:  2018-05-02       Impact factor: 3.850

4.  Coexistence of immune-neuro-endocrine substances in the rat central neurons.

Authors:  C Zhu; Q Liu; Y Wei; C Ma; J Hao; P Yan
Journal:  J Tongji Med Univ       Date:  1999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.